Abstract: In this pharmaceutical composition for treating and/or preventing cancer, a substance that reduces expression of CAPRIN-1 protein on the surfaces of cancer cell membranes, specifically a substance that reduces the amount of expression of CAPRIN-1 protein on the surfaces of cancer cell membranes, or a substance that binds to CAPRIN-1 protein on the surfaces of cancer cell membranes can be used as an active ingredient.
| # | Name | Date |
|---|---|---|
| 1 | 202517101141-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [19-10-2025(online)].pdf | 2025-10-19 |
| 2 | 202517101141-STATEMENT OF UNDERTAKING (FORM 3) [19-10-2025(online)].pdf | 2025-10-19 |
| 4 | 202517101141-Sequence Listing in txt [19-10-2025(online)].txt | 2025-10-19 |
| 5 | 202517101141-Sequence Listing in PDF [19-10-2025(online)].pdf | 2025-10-19 |
| 6 | 202517101141-REQUEST FOR EXAMINATION (FORM-18) [19-10-2025(online)].pdf | 2025-10-19 |
| 7 | 202517101141-PROOF OF RIGHT [19-10-2025(online)].pdf | 2025-10-19 |
| 8 | 202517101141-POWER OF AUTHORITY [19-10-2025(online)].pdf | 2025-10-19 |
| 9 | 202517101141-FORM 18 [19-10-2025(online)].pdf | 2025-10-19 |
| 10 | 202517101141-FORM 1 [19-10-2025(online)].pdf | 2025-10-19 |
| 11 | 202517101141-FIGURE OF ABSTRACT [19-10-2025(online)].pdf | 2025-10-19 |
| 12 | 202517101141-DRAWINGS [19-10-2025(online)].pdf | 2025-10-19 |
| 13 | 202517101141-DECLARATION OF INVENTORSHIP (FORM 5) [19-10-2025(online)].pdf | 2025-10-19 |
| 14 | 202517101141-COMPLETE SPECIFICATION [19-10-2025(online)].pdf | 2025-10-19 |
| 15 | 202517101141-certified copy of translation [22-10-2025(online)].pdf | 2025-10-22 |
| 16 | 202517101141-MARKED COPIES OF AMENDEMENTS [29-10-2025(online)].pdf | 2025-10-29 |
| 17 | 202517101141-FORM 13 [29-10-2025(online)].pdf | 2025-10-29 |
| 18 | 202517101141-AMMENDED DOCUMENTS [29-10-2025(online)].pdf | 2025-10-29 |